维普中文期刊产品整合服务
25篇 您的检索式:作者名="Mondou"
    题名 作者 年代 出处 被引量
1地中海区域邮轮港口发展研究显示文摘地中海区域具有发展邮轮旅游业的多重优势。区域内的众多港口为吸引邮轮公司,获取更大发展而激烈竞争。然而调研的案例表明,这些港口并未因激烈竞争而几败俱伤,反而形成你追我赶、共同发展的良好局面,地中海区域的邮轮旅游业也由此得到持续提升。进入大众旅游时代的中国,邮轮旅游作为一种新的旅游形式正被中国旅游者接受。中国港口所在地政府若能借鉴地中海区域邮轮港口群的经验,类似地中海区域邮轮港口群良性发展的局面也可在中国沿海出现。沈世伟 Mondou Véronique 2014宁波大学学报(人文科学版)2014,27,5:2
2Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature显示文摘Herve Mommeja-Marin Elsa Mondou M.Robert Blum Franck Rousseau 2003Hepatology2003,,6:2
3Serum HBV DNA as a marker of efficacy during therapy for chornie HBV infeetion: analysis and review of the literature 显示文摘Mommeja-Marin H Mondou E 2003Hepatology2003,37,6:1
4Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection:analysis and review of the literature显示文摘Mommeja-Marin H Mondou E Blum MR 2003Hepatology2003,37,6:1
5Characterization of bifidobacteria by random DNA amplification显示文摘Vincent D Roy D Mondou F 1998Int J Food Microblol1998,43,3:1
6A phase 2a, randomized, double‐blind 28‐day study of TZP‐102 a ghrelin receptor agonist for diabetic gastroparesis显示文摘N. Ejskjaer J. M. Wo T. Esfandyari M. Mazen Jamal G. Dimcevski L. Tarnow R. A. Malik P. M. Hellstr?m E. Mondou J. Quinn F. Rousseau R. W. McCallum 2012Neurogastroenterology & Motility2012,,2:1
7Phase 2b, randomized, double‐blind 12‐week studies of TZP ‐102, a ghrelin receptor agonist for diabetic gastroparesis显示文摘R. W. McCallum A. Lembo T. Esfandyari B. R. Bhandari N. Ejskjaer C. Cosentino N. Helton E. Mondou J. Quinn F. Rousseau 2013Neurogastroenterol Motil2013,,11:1
8Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection : analysis and review of the literature显示文摘Mommeja - Matin R Mondou E Blum MR 2003Hepatology2003,37,:1
9Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature 显示文摘Mommeja MH Mondou E Blum MR 2003Hepatology2003,37,:1
10Effect of polymers and storage temperature on the stability of freeze-dried lactic acid bacteria显示文摘Champagne C P Mondou F Raymond Y 1996Food Research International1996,29,:1
11Charateization of Bifidobacteria by random DNA amplification显示文摘Vincent D Roy D Mondou F 1998Int J Food Microbool1998,43,:1
12Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature显示文摘MOMMEJA MARIN H MONDOU E BLUM M R 2003Hepatology2003,37,:1
13Characterization of bifidobacteria by random DNA amplification显示文摘Daniel Vincent Denis Roy Francine Mondou Claude Déry 1998International Journal of Food Microbiology1998,,3:1
14Purification and prop- erties of a xylanase from Streptomyces lividans显示文摘MOROSOLI R BERTRAND J L MONDOU F 1986Biochemical Journal1986,239,3:1
15Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection : Anal- ysis and review of the literature 显示文摘Mommeja-Marin H Mondou E Blum MR 2003Hepatology2003,37,6:1
16Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection:analysis and review of the literature显示文摘Mommeja-Marin H Mondou E Blum R 2003Hepatology2003,37,:1
17Serum HBV DNA as a marker of effi- cacy during therapy for ehornic HBV infeetio: analysis and review of the literature 显示文摘Mommeja - Marin H Mondou E 2003Hepatology2003,37,6:1
18Serum HBV - DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature显示文摘Mommeja -Mariu H Mondou E Blum RM 2003Hepatology2003,37,6:1
19Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature显示文摘Mommeja-Marin H Mondou E Robert Blum M 2003Hepatology2003,37,6:1
20Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature 显示文摘MM HERVE E MONDOU MR BLUM 2003Hepatology2003,37,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费